tangeretin has been researched along with Cognitive Decline in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Bao, J; Gong, X; Liang, Z; Liu, W; Shu, X; Tu, C; Wang, X; Wu, M; Zhao, Y | 1 |
| Chen, M; Du, J; Li, Y; Lu, D; Wang, Z; Wu, B; Xiao, Y; Zhang, F; Zhang, L | 1 |
| Fatima, A; Siddique, YH | 1 |
3 other study(ies) available for tangeretin and Cognitive Decline
| Article | Year |
|---|---|
Tangeretin Inhibits BACE1 Activity and Attenuates Cognitive Impairments in AD Model Mice.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Amyloid Precursor Protein Secretases; Animals; Aspartic Acid Endopeptidases; Cognitive Dysfunction; Disease Models, Animal; Flavones; Mice; Mice, Transgenic | 2022 |
Tangeretin prevents cognitive deficit in delirium through activating RORα/γ-E4BP4 axis in mice.
Topics: Animals; ARNTL Transcription Factors; Cognition; Cognitive Dysfunction; Delirium; Flavones; Lipopolysaccharides; Mice; Tumor Necrosis Factor-alpha | 2022 |
Role of tangeritin against cognitive impairments in transgenic Drosophila model of Parkinson's disease.
Topics: Animals; Animals, Genetically Modified; Brain; Cognitive Dysfunction; Disease Models, Animal; Dose-Response Relationship, Drug; Drosophila; Flavones; Molecular Docking Simulation; Parkinson Disease; Synucleins; Tyrosine 3-Monooxygenase | 2019 |